Stock CERE CEREVEL THERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
42.3 USD +0.57% Intraday chart for Cerevel Therapeutics Holdings, Inc. -0.68% -0.24%
05-08 Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing
MT
AbbVie CEO to Retire; COO Robert Michael Named Successor
MT
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $424,700, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $331,608, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $571,972, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $259,144, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $292,945, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $326,788, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $413,700, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $676,200, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $680,071, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,533,697, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Bought Shares Worth $124,999,986, According to a Recent SEC Filing
MT
Cerevel Therapeutics Holdings Insider Bought Shares Worth $124,999,986, According to a Recent SEC Filing
MT
Insider Buy: Cerevel Therapeutics Holdings
MT
Insider Buy: Cerevel Therapeutics Holdings
MT
Insider Sell: Cerevel Therapeutics Holdings
MT
Insider Sell: Cerevel Therapeutics Holdings
MT
Cerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer, Effective from June 20, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CERE Stock
  4. News Cerevel Therapeutics Holdings, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW